STSN (Stemsation International) Change In Receivables: $0.00 Mil (TTM As of Sep. 2011)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Stemsation International Change In Receivables?

Stemsation International STSN +16.98% Change In Receivables is $0.00 Mil as of Sep. 2011.

Stemsation International's change in receivables for the quarter that ended in Sep. 2011 was $0.00 Mil. It means Stemsation International's Accounts Receivable stayed the same from Jun. 2011 to Sep. 2011 .

Stemsation International's change in receivables for the fiscal year that ended in Dec. 2010 was $0.00 Mil. It means Stemsation International's Accounts Receivable stayed the same from Dec. 2009 to Dec. 2010 .

Stemsation International's Accounts Receivable for the quarter that ended in Sep. 2011 was $0.00 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Stemsation International's Days Sales Outstanding for the three months ended in Sep. 2011 was 0.00.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Stemsation International's liquidation value for the three months ended in Sep. 2011 was $-0.53 Mil.

Stemsation International  (OTCPK:STSN) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Stemsation International's Days Sales Outstanding for the quarter that ended in Sep. 2011 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=0/0.001*91
=0.00

2. In Ben Graham's calculation of liquidation value, Stemsation International's accounts receivable are only considered to be worth 75% of book value:

Stemsation International's liquidation value for the quarter that ended in Sep. 2011 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=0.001-0.528+0.75 * 0+0.5 * 0
=-0.53

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stemsation International Change In Receivables Related Terms

Stemsation International Change In Receivables Historical Data

* Premium members only.

The historical data trend for Stemsation International's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stemsation International Change In Receivables Chart

Stemsation International Annual Data
Trend Dec06 Dec07 Dec08 Dec09 Dec10
Change In Receivables
0.00 -0.01 0.01 0.00 0.00

Stemsation International Quarterly Data
Dec06 Mar07 Jun07 Sep07 Dec07 Mar08 Jun08 Sep08 Dec08 Mar09 Jun09 Sep09 Dec09 Mar10 Jun10 Sep10 Dec10 Mar11 Jun11 Sep11
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Stemsation International Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Sep. 2011 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Receivables →
What does a Change In Receivables of $0.00 Mil mean?
Stemsation International (STSN) has a Change In Receivables of $0.00 Mil as of Sep. 2011. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Stemsation International and its competitors.
Is Stemsation International's Change In Receivables too high?
Stemsation International's current Change In Receivables is $0.00 Mil.
How does Stemsation International's Change In Receivables compare to MAMP and LODE?
Stemsation International's Change In Receivables of $0.00 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Receivables for a Drug Manufacturers company?
A good Change In Receivables depends on the Drug Manufacturers industry context. However, Change In Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Receivables mean?
A high Change In Receivables can signal that a stock is expensive relative to its fundamentals. Change in Receivables is the difference between current-period receivables and past-period receivables. View historical data for Stemsation International and its competitors. Stemsation International's current Change In Receivables is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stemsation International stock overvalued right now?
Stemsation International (STSN) has a current Change In Receivables of $0.00 Mil. The current Change In Receivables is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Receivables calculated?
Change In Receivables is calculated from a company's financial statements. For Stemsation International (STSN), the current Change In Receivables is $0.00 Mil as of Sep. 2011. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Stemsation International Business Description

Address 9555 Bergamot Street, Lake Worth, FL, USA, 33467
Stemsation International Inc is developing a line of canned, flavored oxygen products to be sold business-to-business (B2B) and direct to consumers (DTC). These products will be distributed to the beverage industry, as well as to restaurants and bars. It is also developing R&D and manufacturing relationships for additional products and services.